AKR1B1 and cancer: Trans-(±)-kusunokinin ((±)KU), a synthetic antiproliferative agent that inhibits the growth of several malignant tumor cells both in vitro and in vivo, was shown to be a selective inhibitor of AKR1B1 [179–181].